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ABSTRACT
Objectives: As the aetiology of bacterial vaginosis (BV) is
not well understood, this study sought to determine the
relationships between several fastidious microbes, BV and
selected clinical characteristics of BV.
Methods: Endometrial and cervical specimens from 50
women with non-gonococcal, non-chlamydial endometri-
tis were tested for Leptotrichia sanguinegens/amnionii,
Atopobium vaginae, bacterial vaginosis-associated bac-
teria 1 (BVAB1), Ureaplasma urealyticum biovar 2 (UU-2)
and Ureaplasma parvum using PCR. BV was categorised
using Nugent’s and Amsel’s criteria. Odds ratios (OR)
adjusted for age and race were estimated using
multivariable logistic regression.
Results: Although elevated pH was a universal feature,
other BV characteristics differed by pathogen, suggesting
variable clinical presentation. Only UU-2 was strongly
associated with vaginal discharge, but a positive whiff
test and a 20% or greater classification of epithelial cells
as clue cells were more common among women with L
sanguinegens/amnionii, A vaginae and BVAB1. For each of
these bacteria, there were trends towards associations
with BV defined by Amsel’s criteria (L sanguinegens/
amnionii OR 2.9, 95% CI 0.5 to 15.7; A vaginae OR 2.6,
95% CI 0.6 to 11.4; BVAB1 OR 5.7, 95% CI 1.0 to 31.1)
and significant associations with BV defined by Gram stain
(L sanguinegens/amnionii OR 17.7, 95% CI 2.8 to 113.0; A
vaginae OR 19.2, 95% CI 3.7 to 98.7; BVAB1 OR 21.1,
95% CI 2.2 to 198.5).
Conclusions: L sanguinegens/amnionii, A vaginae and
BVAB1 are associated with clinical characteristics
consistent with BV and BV defined by Nugent’s and
Amsel’s criteria. These fastidious bacteria may cause
unrecognised infection, as none was associated with
abnormal vaginal discharge.
Bacterial vaginosis (BV) is a common lower genital
tract infection that may lead to pelvic inflamma-
tory disease (PID),
1 subsequent infertility
2 and
preterm birth,
3 and may increase susceptibility to
HIV.
4 Although no single agent is known to cause
BV and its aetiology is not well understood,
bacteria such as Gardnerella vaginalis, ureaplasmas,
Mycoplasma hominis and anaerobic bacteria are
commonly isolated from BV patients.
5–7 Until
recently, our understanding of BV microbiology
largely came from cultivated species and Gram-
stained vaginal smear analysis, most notably
Nugent’s criteria.
8 Recently, cultivation-indepen-
dent studies using 16S rDNA sequences PCR
amplified from vaginal DNA have revealed pre-
viously unrecognised bacterial genera associated
with BV. Some of these include metronidazole-
resistant
5 Atopobium vaginae,
569 Leptotrichia
(Sneathia) sanguinegens and Leptotrichia amnionii,
6
and three new species of uncultivated bacteria
termed bacterial vaginosis-associated bacteria
(BVAB) types 1, 2 and 3.
6
Nugent’s criteria
8 measure specific Gram-
stained bacterial morphotypes. Consequently,
organisms that do not Gram stain, such as
ureaplasmas and mycoplasmas, are not measured.
Ureaplasmas have been associated with BV,
10
although modestly in some studies.
7 High rates
of ureaplasma colonisation among patients with-
out clinical disease further complicate interpreta-
tion.
10 11 Moreover, ureaplasmas (formerly
designated Ureaplasma urealyticum but termed
undifferentiated ureaplasmas herein) have
recently been split into two biovars: Ureaplasma
parvum, reported to be non-pathogenic in men;
12
and U urealyticum (biovar 2), associated with
urethritis.
12 13 The role of these newly classified
ureaplasmas in BV has been little studied. In this
analysis, we sought to determine the associations
among several fastidious pathogens and BV
d e f i n e db yG r a ms t a i na n dA m s e l ’ sc r i t e r i aa m o n g
a population of women with PID.
MATERIALS AND METHODS
Population
A subset of previously collected and stored cervical
and endometrial specimens from women who
participated in the PID Evaluation and Clinical
Health (PEACH) Study
14 was analysed. Briefly, the
parent PEACH study recruited 831 women aged
14–37 years with clinically suspected PID between
March 1996 and February 1999 from emergency
departments, obstetrics and gynaecology clinics,
sexually transmitted infection (STI) clinics and
private practices at 13 US clinical sites. All women
gave written informed consent, and University of
Pittsburgh Institutional Review Board approval
was obtained for both the PEACH study and the
substudy described herein. In order to examine the
lower and upper genital tract microbiological
milieu among women with non-gonococcal, non-
chlamydial PID, and additionally to examine the
associations between selected fastidious bacteria
and BV, we conducted a targeted PCR substudy
using stored specimens from 50 randomly selected
women with histologically confirmed non-gono-
coccal, non-chlamydial endometritis. A classifica-
tion of endometritis was given upon finding at
least five neutrophils in the endometrial surface
epithelium in the absence of menstrual endome-
trium and/or at least two plasma cells in the
endometrial stroma.
15
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As part of the current substudy, previously frozen endometrial
biopsy and cervical swab specimens were tested for L sanguine-
gens/amnionii, A vaginae, BVAB1, U urealyticum (biovar 2), and U
parvum using PCR assays. Patient specimens were purified using
the MasterPure DNA purification kit (Epicentre, Madison,
Wisconsin, USA). For the Leptotrichia PCR assay, the published
Leptotrichia-specific primers
6 were optimised for our thermo-
cycling conditions. Leptotrichia-specific PCR products were
detected as approximately 240 bp products on agarose gels.
The specificity of this assay was confirmed by sequencing the
PCR products from four randomly selected specimens; two of
the specimens contained sequences consistent with L amnionii
and two contained sequences consistent with L sanguinegens.
PCR primers targeting the 16S rRNA genes of A vaginae
5 and
BVAB1
6 were 59–GTTAGGTCAGGAGTTAAATCTG–39 and
59–TCATGGCCCAGACC–39 and 59–AGTGTAGGCGGCACT-
ATAAG–39and 59–CGATAACTGACGCTAAGGCT–39, respec-
tively. The PCR conditions were 95uC (5 minutes) followed by
25 cycles of 95uC (1 minute), 62uC (1 minute) A vaginae or 66uC
(1 minute) for BVAB1, 72uC (1 minute) with final extension
72uC for 7 minutes. PCR products (150–200 bp) were visualised
on agarose gels sequenced to confirm specificity.
The U urealyticum (biovar 2) PCR assay was designed to
differentiate the newly recognised species of ureaplasma, U
urealyticum and U parvum, formally called U urealyticum biovar 2
and biovar 1, respectively. The U urealyticum PCR targets
sequences in the urease genes of all 10 serovars of UU-2 not
found in the four U parvum (biovar 1) serovars. Conversely, the
U parvum PCR targets sequences in the urease genes of all U
parvum serotypes not found in the UU-2 serovars. In both
assays, 5 ml purified patient sample was subjected to PCR
amplification in a total volume of 100 ml containing 1 6PCR
buffer (magnesium ion free; Promega, Madison, Wisconsin,
USA), 2.75 mmol magnesium chloride, 200 mmol each of the
four dNTP, 0.1 mmol forward primer, 0.1 mmol reverse primer
and 5 U of Taq DNA polymerase. PCR primers and
amplification conditions for the U urealyticum PCR were:
UUF2 (59–CAC AGA TGT CCT TGA TGT ACC C–39) and
UUR2 (59–GTA AAA ATT ATT TGT AAA TTG GGC–39);
and the following temperatures: 94uC for 4 minutes; 45
cycles of 94uC for 10 s, 56uC for 50 s and 72uCf o r3 0 s ;
followed by 72uC for 5 minutes and a final soak set at 4uC
indefinitely. Primers and conditions for the U parvum PCR
were UpF1 (59–GATCCAATTTACAAATAACA–39)a n d
UpR1 (59–GTAGAAACTTGTAAAATAGAG–39); and 94uC
for 4 minutes; cycle programme (35 cycles); 94uC, 45uC and
72uC for 1 minute each; followed by 72uC for 10 minutes
and a final soak set at 4uC indefinitely. Assay specificities
were confirmed by the detection of the appropriate sized
PCR product (474 and 469 for Uurealyticum and Up a r v u m )o n
agarose gels and reactivity with the UU-2-specific probe (UUDP2
(59–biotin–ATC CAA AAG TTA TTG GTA ACA GTA G–39)a n d
Up a r v u m(59–biotin–GGCAATTAATTTCGCTAGT–39)-specific
probes on Southern blots hybridised at 55uCa n d5 0 uC,
respectively, and visualised on Kodak BioMax XAR film after
reaction in the chemiluminescence assay using the ECL kit
(Amersham GE Healthcare, Little Chalfont, UK).
In a subset of 352 women in the PEACH study, endometrial
biopsy tissue specimens were examined for anaerobic Gram-
negative rods, G vaginalis and M hominis. Twenty-nine women
in the current substudy had culture results. One sample was
used to inoculate a human blood bilayer Tween agar
16 for the
detection of G vaginalis, and a second swab sample was used to
inoculate a Brucella agar for recovery of anaerobic bacteria and
broth media for M hominis recovery.
Vaginal fluid was analysed for bacterial vaginosis by Amsel’s
criteria
17 and by Nugent’s criteria, in which the relative presence
of morphotypes consistent with Lactobacillus spp, Gardnerella
spp, Mobiluncus and anaerobic bacteria is measured by Gram
stain with a score ranging from 0 to 10.
8
Statistical analysis
Comparisons of demographic, sexual and behavioural charac-
teristics, and cultivable comorbid BV bacteria were compared
between women with and without L sanguinegens/amnionii, A
vaginae, BVAB1, UU-2 and U parvum using x
2 tests of
proportions and Fisher’s exact tests. Logistic regression models
were fit with BV as the dependent variable and Leptotrichia, A
vaginae, BVAB1, UU-2 and U parvum as explanatory variables.
Odds ratios (OR) adjusted for age and race were estimated using
multivariable logistic regression. Analyses were performed using
SAS version 9.1 for Windows.
RESULTS
All bacteria analysed were common among women with PID. L
sanguinegens/amnionii, A vaginae, BVAB1, UU-2, and U parvum
were detected in 62%, 54%, 28%, 32% and 32% of women
tested, respectively. There was a high degree of agreement
between cervical and endometrial PCR (Leptotrichia: Phi
coefficient 0.75, p,0.001; BVAB1: Phi coefficient 0.33,
p,0.05; U ureaplasma (biovar 2): Phi coefficient 0.49,
p,0.005; and U parvum Phi coefficient 0.31, p,0.05). All
endometrial Leptotrichia, BVAB1, U ureaplasma (biovar 2) and U
parvum-positive cases were also positive at the cervix. Seventy-
seven per cent of Leptotrichia, 14% of BVAB1, 31% of U
ureaplasma (biovar 2) and 13% of U parvum cervical positive
cases were also positive in the endometrium. Although the
relationship between cervical and endometrial PCR was not
statistically significant, 80% of endometrial A vaginae-positive
cases were also positive at the cervix and 15% of cervical positive
cases were positive in the endometrium.
Demographic characteristics and variables comparing medi-
cal, sexual and behavioural history stratified by bacteria
detected are presented in table 1. Women who tested positive
for L sanguinegens/amnionii were significantly more likely to be
black (OR 4.9, 95% CI 1.4 to 16.9) and to have douched within
the last month (OR 3.1, 95% CI 1.0 to 10.2). Similarly, women
who tested positive for A vaginae were more likely to be
uninsured (OR 6.1, 95% CI 1.2 to 30.1), report a history of
Trichomonas vaginalis (OR 9.3, 95% CI 1.1 to 80.9) and to have
douched in the last month (OR 3.1, 95% CI 1.0 to 9.9). None of
the characteristics analysed were statistically associated with
UU-2, U parvum, or BVAB1. Characteristic profiles were similar
to those among women with positive M hominis and G vaginalis
cultures, bacteria traditionally associated with BV, although cell
sizes were small and not all comparisons were statistically
significant (table 2). In addition, women testing positive for M
hominis were 18 times as likely to report a history of PID (OR
18.0, 95% CI 1.1 to 299.0).
Anaerobic bacteria, M hominis and G vaginalis were detected
more often in women with L sanguinegens/amnionii and A
vaginae, although only the association between Leptotrichia and
anaerobic bacteria was statistically significant (table 3). G
vaginalis was cultured from the endometrium significantly more
often among women testing positive for U parvum, but not
among women testing positive for UU-2. BVAB1 was not
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considered in our analyses.
Women in whom L sanguinegens/amnionii, A vaginae and
BVAB1 were detected were generally more likely to have each of
Amsel’s criteria for BV, although not all associations were
statistically significant (see table 4). All bacteria except for U
ureaplasma (biovar 2) and U parvum were more likely to be
categorised as having BV defined both by Amsel’s criteria (L
sanguinegens/amnionii adjusted OR 2.9, 95% CI 0.5 to 15.7; A.
vaginae adjusted OR 2.6, 95% CI 0.6 to 11.4; and BVAB1
adjusted OR 5.7, 95% CI 1.0 to 31.1) and by Nugent’s Gram
stain criteria (L sanguinegens/amnionii adjusted OR 17.7, 95% CI
2.8 to 113.0; A vaginae adjusted OR 19.2, 95% CI 3.7 to 98.7; and
BVAB1 adjusted OR 21.1, 95% CI 2.2 to 198.5). Results were
generally similar to those for M hominis and G vaginalis,
established BV-associated species, although cell sizes for
comparisons of these cultured bacteria were small and not all
comparisons were statistically significant.
DISCUSSION
We conclude that L sanguinegens/amnionii, A vaginae and BVAB1
are associated with BV defined by Gram stain and Amsel’s
criteria among women with histologically confirmed PID.
Consistent results using varying BV definitions suggest robust
findings. Our results agree with those reported by Ferris et al,
5 in
which A vaginae was present in 55% of BV patients compared
with 8% of controls and Fredricks et al,
6 in which A vaginae,
Leptotrichia and BVAB were all associated with BV defined using
Amsel’s criteria. The role of newly classified ureaplasma biovars
in BV has not been widely studied, and to our knowledge, ours
is the first to compare BV among women with and without U
parvum. Our null finding is consistent with evidence demon-
strating no relationship between U parvum and urethritis in
men.
12 Only one published study has examined the relationship
between UU-2 and BV, reporting that among 49 women
delivering preterm, UU-2 was more frequent among those with
compared with those without clinically diagnosed BV (OR 15.0,
95% CI 1.2 to 209.0).
18 Although BV by Amsel’s and Nugent’s
criteria were both more common among women testing positive
forUU-2,comparedwithwomentesting negative forthisbacteria
(57%vs50%and64%vs53%,respectively),thesedifferenceswere
modest and not statistically different in our study.
To our knowledge, our study is the first to compare a range of
clinical characteristics consistent with BV among women with
and without these fastidious bacteria. Although L sanguinegens/
amnionii, A vaginae and BVAB1 were all associated with BV
defined using both Nugent’s and Amsel’s criteria, and elevated
pH was a universal feature, other BV characteristics differed by
pathogen, suggesting variable clinical presentations. Only UU-2
was associated with vaginal discharge, whereas a positive whiff
test was significantly more common among women testing
positive for BVAB1, and a 20% or greater classification of
epithelial cells as clue cells was more common among women
testing positive for L sanguinegens/amnionii, A vaginae,o r
BVAB1. As UU-2 has been associated with urethritis in
men,
12 13 and it was associated with vaginal discharge and
elevated pH but had the weakest relationship with the
Table 2 Characteristics of women with and without M hominis and G vaginalis cultured from the endometrium
Characteristic
M hominis+ M hominis2
OR (95% CI)
G vaginalis+ G vaginalis2
OR (95% CI)
n=3 n=2 1 n=9 n=2 0
No (%) No (%) No (%) No (%)
Demographic
Age, years
,25 2 (66.7) 12 (57.1) 5 (55.6) 14 (70.0)
>25 1 (33.3) 9 (42.9) 1.5 (0.1 to 19.2) 4 (44.4) 6 (30.0) 0.5 (0.1 to 2.7)
Race/ethnicity
African American 2 (66.7) 9 (42.9) 7 (77.8) 8 (40.0)
White/Hispanic/other 1 (33.3) 12 (57.1) 2.7 (0.2 to 34.2) 2 (22.2) 12 (60.0) 5.3 (0.9 to 32.0)
Education
,High school 1 (33.3) 6 (28.6) 4 (44.4) 6 (30.0)
>High school 2 (66.7) 15 (71.4) 1.3 (0.1 to 16.5) 5 (55.6) 14 (70.0) 1.9 (0.4 to 9.5)
Insured
No 2 (100.0) 9 (64.3) 2 (50.0) 10 (71.4)
Yes 0 (0.0) 5 (35.7) – 2 (50.0) 4 (28.6) 0.4 (0.04 to 3.9)
Medical history
History of STI 3 (100.0) 13 (61.9) – 4 (44.4) 13 (65.0) 0.4 (0.1 to 2.1)
History of GC 1 (33.3) 5 (23.8) 1.6 (0.2 to 21.6) 2 (22.2) 4 (20.0) 1.1 (0.2 to 7.8)
History of CT 2 (66.7) 9 (42.9) 2.7 (0.2 to 34.2) 2 (22.2) 9 (45.0) 0.4 (0.1 to 2.1)
History of Trichomonas 2 (66.7) 3 (14.3) 12.0 (0.8 to 177.4) 3 (33.3) 3 (15.0) 2.8 (0.4 to 18.0)
History of BV 2 (66.7) 3 (14.3) 12.0 (0.8 to 177.4) 1 (11.1) 4 (20.0) 0.5 (0.1 to 5.2)
History of PID 2 (66.7) 2 (10.0) 18.0 (1.1 to 299.0) 0 (0.0) 3 (15.0) –
Sexual history
Sexually active 3 (100.0) 19 (90.5) – 8 (88.9) 18 (90.0) 0.9 (0.1 to 11.3)
Rare/occasional condom use* 1 (33.3) 14 (73.7) 0.2 (0.01 to 2.4) 7 (87.5) 11 (61.1) 4.5 (0.5 to 44.4)
New sexual partner 1 (33.3) 3 (14.3) 3.0 (0.2 to 44.4) 2 (22.2) 0 (0.0) –
Behavioural
Douched within last month 2 (66.7) 9 (42.9) 2.7 (0.2 to 34.2) 6 (66.7) 7 (35.0) 3.7 (0.7 to 19.6)
Drug use 0 (0.0) 6 (28.6) – 4 (44.4) 2 (10.0) 7.2 (1.01 to 20.0)
Current smoker 0 (0.0) 10 (47.6) – 6 (66.7) 8 (40.0) 3.0 (0.6 to 15.6)
*Condoms used in 0–5 out of 10 sexual encounters. BV, bacterial vaginosis; CT, Chlamydia trachomatis; GC, gonococcus; OR, odds ratio; PID, pelvic inflammatory disease;
STI, sexually transmitted infection.
Clinical
Sex Transm Infect 2009;85:242–248. doi:10.1136/sti.2008.032821 245remaining BV characteristics, it is tempting to speculate that
this bacterium could be associated with cervicitis. With the
exception of M hominis, none of the bacteria studied were
associated with a history of BV, suggesting the possibility of
previous asymptomatic BV among women with Leptotrichia, A
vaginae and BVAB1. The relationship between BVAB1 and clue
cells is supported by a fluorescence in-situ hybridisation study
published by Fredricks and colleagues,
6 in which BVAB were
found to attach to vaginal epithelial cells, similar to the clue
cells characteristic of BV.
Our findings suggest that L sanguinegens/amnionii and A
vaginae may be associated with sexual activity, as characteristics
associated with STI, including uninsured status, STI history and
report of a new sexual partner, were associated with these
bacteria, although not all comparisons were statistically
significant. Data supporting sexual activity associations with
ureaplasmas and BVAB were less compelling. Women testing
positive for Leptotrichia were nearly five times as likely to be
African-American, although no other bacteria were significantly
associated with race. Douching was among the strongest risk
factors in our study, with women harbouring L sanguinegens/
amnionii and A vaginae being three times more likely to report
douching, although confidence intervals included one demon-
strating borderline associations. Similarly, women with BVAB1
were almost twice as likely to report douching, although this
difference was not significant. These findings are consistent
with evidence showing that douching, through alteration of the
vaginal flora, is associated with BV.
19
It is possible that although these novel bacteria are frequent
among women with BV, they do not play a pathogenic role. A
limitation of our pilot study is the small sample size and the
culture of G vaginalis and M hominis in only a subset of the
parent study, which did not allow adjustment for other
pathogens. The associations between Leptotrichia, A vaginae,
BVAB1 and BV by Gram stain may merely suggest that these
bacteria frequently co-inhabit the lower genital tract of women
with other BV pathogens. In fact, our study shows that G
vaginalis, anaerobic bacteria and M hominis are more common
among women with compared with women without L
sanguinegens/amnionii and A vaginae. This supposition is
supported by a study of 55 women attending a gynaecology
outpatients clinic, in which 50% of A vaginae patients were
found to co-harbour G vaginalis, an organism frequently
identified among women with BV.
20 In addition, biofilms
composed of both G vaginalis and A vaginae are prominent
among women with BV.
21 Alternatively, G vaginalis may not be
pathogenic, but rather a marker for infection with other
fastidious bacteria, because G vaginalis is also frequent among
women without BV
6 and is not associated with other
reproductive morbidity.
BV and BV-associated microorganisms are associated with
PID,
1 although the microbial aetiology of non-gonococcal, non-
chlamydial PID is not completely characterised. As L sanguine-
gens/amnionii, A vaginae, BVAB1, UU-2 and U parvum were
highly prevalent, our findings suggest that several newly
recognised species may play a role in the aetiology of a
significant number of non-gonococcal, non-chlamydial PID
cases. Although cross-sectional, our findings also suggest that
these pathogens may ascend from the lower to the upper genital
tract, as evidenced by a high degree of agreement between
cervical and endometrial PCR. The quest to determine novel
PID pathogens is of great interest, as Neisseria gonorrhoeae and/
or Chlamydia trachomatis are only recovered from approximately
a third to a half of women with PID,
19 22 resulting in an
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cases. Our findings support the need for additional studies
examining these fastidious BV-associated bacteria among
women with and without PID. Furthermore, although we
could not examine gonococcal and chlamydial co-infection in
our study, the possibility that infection with fastidious BV-
associated bacteria may further increase the risk of upper genital
tract infection among women with chlamydia or gonorrhoea
should be explored in subsequent studies.
Although evidence for a role between newly identified BV-
associated organisms and PID is limited, the high prevalence of
these pathogens in our study is consistent with a handful of case
studies, suggesting associations between Av a g i n a eand tubo-
ovarian abscess,
23 and L sanguinegens/amnionii and postpartum
fever, endometritis, adnexal masses and fetal death.
24–26
Furthermore, in a study of 45 women with salpingitis and 44
women seeking tubal ligations, broad-range 16S rDNA PCR was
used to identify bacterial 16S sequences in the fallopian tube
Table 4 Associations between fastidious bacteria identified by PCR, cultured bacteria and bacterial
vaginosis determined by Gram stain and Amsel’s criteria
Bacterial vaginosis variable Positive % Negative %
Crude OR
(95% CI)
Adjusted OR*
(95% CI)
L sanguinegens/amnionii
Discharge 41.9 38.9 1.1 (0.4 to 3.7) 0.8 (0.2 to 2.9)
Vaginal ph .4.5 95.7 68.8 10.0 (1.0 to 96.4) 14.5 (1.2 to 173.0)
Whiff test 51.6 36.8 1.8 (0.6 to 5.9) 1.8 (0.5 to 6.6)
Clue cells .20% 63.3 31.6 3.7 (1.1 to 12.7) 5.7 (1.3 to 25.0)
BV: Amsel’s criteria 60.9 40.0 2.3 (0.6 to 8.8) 2.9 (0.5 to 15.7)
BV: Nugent’s criteria 75.0 25.0 9.0 (2.2 to 37.2) 17.7 (2.8 to 113.0)
UU-2
Discharge 62.5 30.3 3.8 (1.1 to 13.5) 3.4 (0.93 to 12.41)
Vaginal ph .4.5 100.0 76.0 – –
Whiff test 50.0 44.1 1.3 (0.4 to 4.2) 1.3 (0.4 to 4.7)
Clue cells .20% 43.8 54.6 0.7 (0.2 to 2.2) 0.7 (0.2 to 2.4)
BV: Amsel’s criteria 57.1 50.0 1.3 (0.4 to 5.1) 1.5 (0.3 to 6.8)
BV: Nugent’s criteria 64.3 53.3 1.6 (0.4 to 5.8) 1.7 (0.4 to 6.9)
UP
Discharge 35.7 40.6 0.8 (0.2 to 3.0) 0.8 (0.2 to 2.9)
Vaginal ph .4.5 81.8 88.5 0.6 (0.1 to 4.) 0.4 (0.04 to 3.8)
Whiff test 33.3 50.0 0.5 (0.1 to 1.8) 0.5 (0.1 to 1.8)
Clue cells .20% 46.7 54.8 0.7 (0.2 to 2.5) 0.7 (0.2 to 2.5)
BV: Amsel’s criteria 40.0 57.7 0.5 (0.1 to 2.2) 0.4 (0.1 to 2.3)
BV: Nugent’s criteria 61.5 55.2 1.3 (0.3 to 4.9) 1.4 (0.4 to 5.3)
A vaginae
Discharge 44.4 36.4 1.4 (0.4 to 4.4) 1.2 (0.35 to 3.93)
Vaginal ph .4.5 100.0 64.7 – –
Whiff test 59.3 30.4 3.3 (1.0 to 10.8) 3.3 (1.0 to 11.3)
Clue cells .20% 66.7 31.8 4.3 (1.3 to 14.3) 4.5 (1.3 to 16.0)
BV: Amsel’s criteria 63.6 37.5 2.9 (0.8 to 11.1) 2.6 (0.6 to 11.4)
BV: Nugent’s criteria 83.3 25.0 15.0 (3.4 to 65.6) 19.2 (3.7 to 98.7)
BVAB1
Discharge 50.0 37.1 1.7 (0.5 to 5.9) 1.7 (0.5 to 6.0)
Vaginal ph .4.5 100.0 76.9 – –
Whiff test 78.6 33.3 7.3 (1.7 to 31.3) 8.7 (1.9 to 40.4)
Clue cells .20% 85.7 37.1 10.2 (2.0 to 52.7) 12.6 (2.2 to 71.4)
BV: Amsel’s criteria 76.9 40.0 5.0 (1.1 to 22.8) 5.7 (1.0 to 31.1)
BV: Nugent’s criteria 92.3 41.9 16.6 (1.9 to 144.2) 21.1 (2.2 to 198.5)
M hominis
Discharge 66.7 35.0 3.7 (0.3 to 48.6) 3.6 (0.3 to 50.1)
Vaginal ph .4.5 100.0 84.2 – –
Whiff test 100.0 47.6 – –
Clue cells .20% 100.0 57.1 – –
BV: Amsel’s criteria 100.0 100.0 – –
BV: Nugent’s criteria 100.0 57.9 – –
G vaginalis
Discharge 33.3 26.3 1.4 (0.3 to 7.8) 1.2 (0.2 to 7.4)
Vaginal ph .4.5 85.7 82.4 1.3 (0.1 to 15.0) 0.6 (0.03 to 11.4)
Whiff test 55.6 35.0 2.3 (0.5 to 11.5) 2.7 (0.5 to 15.8)
Clue cells .20% 77.8 40.0 5.3 (0.9 to 32.0) 6.1 (0.9 to 43.3)
BV: Amsel’s criteria 71.4 31.2 5.5 (0.8 to 38.7) 17.7 (1.3 to 248.1)
BV: Nugent’s criteria 88.9 43.8 10.3 (1.0 to 102.8) 6.6 (0.6 to 69.6)
*Adjusted for age and race. BV, bacterial vaginosis; BVAB1, bacterial vaginosis-associated bacteria type 1; OR, odds ratio;
UP, Ureaplasma parvum; UU-2, Ureaplasma urealyticum biovar 2.
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27 Bacteria
phylotypes closely related to Leptotrichia spp and Av a g i n a ewere
among those identified in cases.
In summary, PID patients infected with L sanguinegens/
amnionii, A vaginae and BVAB1 were more likely than women
testing negative by PCR to have BV. Our study suggests that
although these pathogens are associated with BV, these novel
bacteria may cause unrecognised infection, as none were
associated with abnormal vaginal discharge and only Leptotrichia
was associated with a previous history of BV. Lack of vaginal
discharge may hinder patient and clinical recognition of BV,
suggesting that a number of cases may currently go undetected.
As these bacteria have been found to have a high sensitivity and
specificity for BV determined by Gram stain,
28 routine screening
using targeted PCR may be warranted to prevent sequelae among
asymptomatic women who would otherwise be undiagnosed.
Furthermore,current treatment regimens may beinadequatefor a
number of women with BV, as A vaginae has been found to be
metronidazole resistant.
5 As the effectiveness of currently
recommended BV treatments for women with L sanguinegens/
amnionii and BVAB is unknown, further studies are needed in
order to optimise treatment and prevent sequelae.
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Key messages
c L sanguinegens/amnionii, A vaginae, bacterial vaginosis-
associated bacteria type 1 (BVAB1), Ureaplasma urealyticum
biovar 2 and U parvum were commonly identified in cervical
and endometrial specimens collected from women with
histologically confirmed endometritis.
c Fastidious anaerobic bacteria, including L sanguinegens/
amnionii, A vaginae and BVAB1, were associated with clinical
characteristics consistent with bacterial vaginosis (BV) and BV
defined by Nugent’s and Amsel’s criteria.
c As none were associated with abnormal vaginal discharge,
these anaerobes may cause unrecognised infection.
c Routine screening using targeted PCR may be warranted to
prevent sequelae among asymptomatic women who would
otherwise be undiagnosed.
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